INTRODUCTION
============

Poliovirus (PV), known to be the causative agent of poliomyelitis, is a human enterovirus that belongs to the Picornaviridae. After oral ingestion of PV in humans, the virus may suffer the low pH in stomach to decrease its viability ([@B12]; **Figure [1](#F1){ref-type="fig"}**). Then, the virus multiplies in the alimentary mucosa ([@B1]; [@B21]), and moves into the bloodstream. The circulating virus invades the central nervous system (CNS) and replicates in motor neurons (MNs). Paralytic poliomyelitis occurs as a result from destruction of MNs by PV replication. In terms of routes for PV dissemination, there are three main routes; transmission from the alimentary mucosa to blood (**Figure [1A](#F1){ref-type="fig"}**; [@B1]; [@B21]), permeation through the blood--brain barrier (BBB) into brain (**Figure [1B](#F1){ref-type="fig"}**; [@B24]), and transmission via peripheral MNs from muscle into brain (**Figure [1C](#F1){ref-type="fig"}**; [@B3]; [@B11]; [@B19]; [@B16]). The species specificity of this virus is governed by a specific cell surface molecule that serves as the PV receptor (PVR). Indeed, transgenic (Tg) mice carrying the human PVR (hPVR/CD155) gene show susceptibility to PV, although mice are generally not susceptible to the virus ([@B20]; [@B8]). Tg mice are susceptible to PV when the mice are infected via intravenous and intramuscular routes but not via oral routes ([@B20]; [@B8], [@B6], [@B7]; [@B18], [@B19]; [@B2]; [@B25]). The Tg mice became susceptible to oral infection when interferon (IFN)-α/β receptor gene is disrupted ([@B12]). The two dissemination routes through BBB and MNs are also functional in PV-sensitive Tg mice, whereas the routes through alimentary mucosa is not functional in PV-sensitive Tg mice with normal IFN-α/β response.

![**Dissemination pathway for PV in human**. Oral ingested PV invades into blood through alimentary tract **(A)** followed by viremia. The virus in the blood permeates BBB into CNS **(B)**. PV also invades into CNS directly by neural pathway through MNs from skeletal muscle to CNS **(C)**.](fmicb-03-00147-g001){#F1}

PVR-DEPENDENT AND -INDEPENDENT RETROGRADE AXONAL TRANSPORT FROM MUSCLE TO CNS
=============================================================================

Axonal transport is a cellular process responsible for movement of mitochondria, lipids, synaptic vesicles, proteins, and organelles to and from a neuron's cell body, through the cytoplasm of its axon. It is well known that some viruses, such as Rabies virus, hijacks the retrograde axonal transport, i.e., from synapse to cell body, to invade the CNS ([@B23]). Using a PV-sensitive Tg mouse line, we have shown that intramuscularly inoculated PV is taken up by endocytosis at synapses (**Figure [1C](#F1){ref-type="fig"}**; [@B13]). PV is able to invade the CNS by traveling on this cargo. The vesicles containing intact PV particles are transported retrogradely along with the axon without initiating uncoating ([@B16]). The uncoating event takes place at the cell body of the MN. We demonstrated that a fast retrograde axonal transport process is required for PV dissemination through the sciatic nerve of hPVR-Tg mice and that intramuscularly inoculated PV causes paralytic disease in a hPVR-dependent manner ([@B16]). We also showed that hPVR-independent axonal transport of PV exists in hPVR-Tg and non-Tg mice, indicating that several different pathways for PV axonal transport exist in these mice ([@B15]). The velocity of hPVR-independent axonal transport of PV (\~0.5 μm/s) is slower than hPVR-dependent axonal transport (\>0.5 to \~3.7 μm/s) *in vivo.* Using primary MNs isolated from these mice or rats, we demonstrated that the axonal transport of PV requires several kinetically different motor machineries ([@B15]). The fast speed component was ≥ 1.4 μm/s, whereas the slow component was centered between 0.4 and 1.0 μm/s. Using a mutant hPVR, that has a lower affinity to cytoplasmic dynein than intact hPVR, we revealed that the fast transport relies on a system involving cytoplasmic dynein ([@B13]).

AXONAL TRANSPORT OF PV *IN VIVO* AND IN CULTURED MNs
====================================================

Unexpectedly, the hPVR-independent incorporation of PV followed by the axonal transport was not observed in cultured MNs. Thus, PV transport machineries in cultured MNs and *in vivo* differ in their hPVR requirements ([@B15]). **Figure [2](#F2){ref-type="fig"}** summarizes the PV transports depending on the cell types. In hPVR-Tg mice, most of the hPVR-containing vesicles are retrogradely transported with fast kinetics in an hPVR-dependent manner. PV is also transported in a hPVR-independent manner with slow kinetics by an unknown mechanism. Indeed, PV is transported with slow kinetics in non-Tg mice. In isolated MNs, only hPVR-dependent PV endocytosis is detected. No endocytosis of PV is detected in control cultured MNs lacking hPVR. These results suggest that the axonal trafficking of PV is carried out by several distinct pathways, and that MNs in culture and in the sciatic nerve *in vivo* are fundamentally different in the uptake and axonal transport of PV.

![**Mechanisms for hPVR-dependent and -independent transport of PV in MNs. (A)** In hPVR-Tg mice, PV is endocytosed after interacting to hPVR **(Aa)**. Most of the hPVR-containing vesicles are retrogradely transported in an hPVR-dependent manner with fast kinetics **(Ac)**. hPVR-independent endocytosis **(Ab)** and transport **(Ae)** of PV also occur. The hPVR-independent endocytosis is possibly mediated by an unidentified PV receptor expressed at neuromuscular junctions. Alternatively, hPVR-independent endocytosis may be promoted by synaptic activity *in vivo*. PV-containing vesicles with or without hPVR can be retrogradely transported in an hPVR-independent manner with slow kinetics (**Ad** and **Ae**). **(B)** In non-Tg mice, PV is endocytosed and transported with slow kinetics in an hPVR-independent manner **(Be)**. The hPVR-independent endocytosis is possibly mediated by the unidentified PV receptor expressed at neuromuscular junctions **(Bb)**. **(C)** In cultured MNs, only hPVR-dependent PV endocytosis is detected **(Ca)**.The hPVR-dependent transport shows fast kinetics **(Cc)**. It might be possible that the slow component in cultured MNs **(Cd)** requires hPVR for endocytosis, whereas its transport may be hPVR-independent. **(D)** No endocytosis of PV is detected in cultured MNs lacking hPVR, possibly due to the absence of the unidentified PV receptor.](fmicb-03-00147-g002){#F2}

For elucidating the precise mechanisms of infection in MNs, it is important to establish a culture system closely mimicking *in vivo*. MNs in culture and in the sciatic nerve *in vivo* are different in the uptake and axonal transport of PV ([@B15]). The differences might be due to the lack of neuromuscular junctions in MNs in culture. Furthermore, MNs are infected both at synapse side and cell body side in conventional culture system, whereas the natural infection occurs mainly at the synapse side *in vivo*. To reflect the conditions *in vivo*, we applied microfluidic culture platform made of polydimethylsiloxane (PDMS) that polarizes the growth of neural axons fluidically isolated environment ([@B22]; [@B17]), which enables infection with PV only from synapse side or cell body side. Using the system, we indicated that the infection from the synapse side intrinsically differ from the infection from the cell body side (author's unpublished data). This system may enable co-culture of the synapse side of MNs with muscular cells to form neuromuscular junctions, which more closely mimic *in vivo*, and will shed light on the precise analysis of early infection with infectious agents in MNs in culture.

TRANSFERRIN RECEPTOR-DEPENDENT BBB PERMEATION
=============================================

Vascular endothelial cells make up the walls that are sealed together at their edges by tight junctions. BBB does not allow the free transportation of materials including pathogens between the bloodstream and parenchyma of the CNS and blocks viral infection in the CNS. Evidences that support PV invasion of BBB by infecting endothelial cells *in vivo* have not been reported. PV is believed to invade the CNS through the BBB. PV permeation through BBB is hPVR-independent and fast as cationized rat serum albumin which is known to permeate the BBB at a high rate ([@B24]). Similarly, using transwell *in vitro* BBB model involving mouse brain capillary endothelial cells (MBEC4), we demonstrated that BBB permeation of PV is hPVR-independent and fast as that of transferrin (**Figure [3](#F3){ref-type="fig"}**, author's unpublished data). These evidences strongly suggest the presence of a new PV receptor for BBB permeation. To elucidate the new PV receptor which interacts with PV, we analyzed the PV-interacting protein by mass spectrometry. As a result, we identified mouse transferrin receptor 1 (TfR1), a membrane bound receptor for transferrin, as a binding protein to PV. Furthermore, peptide sequences of mouse TfR1 and PV involved in the binding were identified (author's unpublished data; the data will be published on another paper). The identified peptide of PV had a permeation activity in *in vitro* BBB model using MBEC4 cells cultured in transwell, and the permeation was fast as transferrin (**Figure [3](#F3){ref-type="fig"}**). Therefore, mouse TfR1 is a possible receptor of PV for the BBB permeation. As for the homology of TfR1 between mouse and human, both mouse TfR1 and human TfR1 conserve function of iron delivery and the binding site of TfR1 has higher sequence homology (89%) between human and mouse TfR1 than the full length TfR1 molecule (77%). The homology indicates that human TfR1 may function as a PV receptor for the BBB permeation in natural infection in human.

![**Models for BBB permeation of PV**. TfR1 attaches to PV **(A)**, transferrin **(B)**, or PV peptide **(C)** and transported through brain capillary endothelial cells into brain by a fast process. On the other hand, dextran (MW \> 15 K) is not transcytosed by TfR1 and leaks between cell junctions by a slow process **(D)**.](fmicb-03-00147-g003){#F3}

Surprisingly, the majority of the PV related materials after the BBB permeation were intact infectious particles in the brain of hPVR-Tg mice and non-Tg mice ([@B24]). Moreover, the permeated materials contained infectious particles in *in vitro* BBB model (author's unpublished data). These evidences indicate that PV retains infectivity during the BBB permeation, the transcytosis through capillary endothelial cell layers. At present, it cannot be excluded that TfR1 could actually be the long sought after molecule involved in the hPVR-independent axonal transport of PV *in vivo*. TfR1 is expressed in MNs in mouse spinal cord ([@B5]), supporting the hypothesis that TfR1 exists in MNs of sciatic nerve and serves to facilitate hPVR-independent axonal transport. MNs extending neurite in culture express only a small amount of TfR1 ([@B10]), which is consistent with the lack of PV incorporation into MNs in culture ([@B15]).

DISSEMINATION THROUGH ALIMENTARY MUCOSA
=======================================

The mechanism of the dissemination through alimentary mucosa is unclear (**Figure [1A](#F1){ref-type="fig"}**). The instability of the virus in the gastric environment decreases the efficiency of the oral infection in mice ([@B14]). Furthermore, we have shown that IFN-α/β plays an essential role in preventing PV from replicating in the intestines using hPVR-Tg mice with or without IFN-α/β receptor expression ([@B14]). Recently, [@B9] reported that intestinal bacteria promote PV replication and systemic pathogenesis using hPVR-Tg mice without IFN-α/β receptor expression, indicating that intestinal microbes may enhance PV intestinal infection even in human. In terms of the receptor localization in polarized epithelial cells, hPVRα, one of the two identified membrane bound forms of hPVR, shows basolateral localization due to its basolateral sorting signal, whereas hPVRδ, another membrane bound form of hPVR, non-polarized localization ([@B14]). hPVRs mainly localizes to the basolateral in human colon carcinoma (Caco-2) epithelia cells ([@B14]) and human Peyer's patches including human microfold cells (M cells), that are distinctive mucosal epithelial cells mediating immune surveillance ([@B4]). Nevertheless, PV efficiently permeates alimentary mucosa from the apical side into bloodstream, suggesting the possibility that a small amount of apical hPVR or another PV receptor besides hPVR contributes to the transport. It should be noted that PV does not replicate in the alimentary tracts of hPVR-Tg mice that express high levels of hPVR in the intestinal epithelial cells after oral administration ([@B25]) in contrast to its behavior in humans. Much work should be done to elucidate mechanisms of PV infection in and dissemination from the alimentary tract.

CONCLUSION
==========

We demonstrated that axonal transport of PV includes hPVR-dependent and -independent pathways, implying the involvement of a new receptor for PV besides hPVR. We also demonstrated that PV permeates BBB at a high rate in an hPVR-independent manner, and we implicated a new possible receptor for PV to permeate the BBB. Thus, PV receptors including hPVR and new possible receptors play important roles for PV dissemination. It is important to elucidate new possible receptors in the future to clarify the precise mechanisms for PV dissemination pathways. Additionally, we revealed that the discrepancy exists between *in vivo* and in cultured MNs. It would be useful to establish adequate systems in culture for elucidating the transport mechanisms of PV. The discrepancy itself might be a clue for understanding the event *in vivo*.
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